Keep taking the blood pressure medicine during the pandemic

December 08, 2020

Each day, at least half a million Danes take a small pill to keep their blood pressure down or to protect against heart disease, and they should continue to take the medicine during the pandemic - even if the pill they take is an ACE inhibitor or Angiotensin II receptor blocker such as Losartan, Enalapril or Ramipril.

This is underscored by a new reassuring study, which, unlike all previous studies, also includes all Danes who have been tested for corona over a five month period - and not 'just' the most ill patients who have been hospitalised.

The researcher behind the research result is Christian Fynbo Christiansen, who is consultant, clinical associate professor and PhD at the Department of Clinical Epidemiology, which is part of the Department of Clinical Medicine at Aarhus University and Aarhus University Hospital, Denmark.

"The study finally removes any lingering suspicion that this particular type of blood pressure medicine increases the risk of getting corona or of suffering a worse illness, which was something that many health professionals feared while we were learning about corona. But there is no evidence to conclude such fears are correct," says Christian Fynbo Christiansen.

In the study, which includes all Danes who were tested in the period from 27 February to 26 July this year, the researchers have examined whether users of the popular blood pressure medications had an increased probability of a positive corona test, and whether the outcome of any illness was different than that of users of other types of blood pressure medication. The comparison group also includes people who do not take blood pressure medication.

"The study shows that people who take ACE inhibitors and Angiotensin II receptor blockers had the same probability of a positive test - and no increased risk of being hospitalised or dying," says Christian Fynbo Christiansen, who can thus confirm in a large-scale study what other smaller studies have already hinted at.

The new study is published in the journal Thorax and is part of a discussion about treatment that peaked in the early summer, when the coronavirus was still a new acquaintance. At the time, medical doctors and researchers feared that ACE inhibitors could actually increase the risk of dying from COVID-19, because the SARS-CoV-2 virus which causes COVID-19 enters the lungs through the same ACE receptors as the ACE inhibitors.

The hypothesis was that when the ACE inhibitor does what its name states and reduces the level of ACE, the body compensates for this by activating a far greater number of ACE receptors on the surface of the cells, which the SARS-CoV-2 virus then utilises as a kind of access key. The more keys available on the surface of the cells, the easier it is for the virus to access the cells.

"The theory about increased mortality was nourished by the fact that many of the severely ill COVID-19 patients had elevated blood pressure, which is widely treated with these ACE inhibitors. This is also why it was important to include all the Danes who had been tested - and not just those who were hospitalised - in the study," says Christian Fynbo Christiansen.

"We have a qualified basis to reiterate the current recommendation that users of medicines of the type ACE inhibitors and Angiotensin II blockers should continue to take their medicine while the pandemic is raging," he says.
-end-
Facts about ACE inhibitors and Angiotensin II receptor blockers:

ACE inhibitors are a group of drugs which expand the blood vessels so that blood pressure is lowered and the work of the heart becomes easier. An ACE inhibitor dampens the enzyme in the body which ensures that the inactive angiotensin I is converted into the active angiotensin II. Angiotensin II causes contraction of the blood vessels. When the body forms less angiotensin II, the blood vessels relax and blood pressure decreases. The acronym ACE stands for Angiotensin Converting Enzyme. As the name suggests, angiotensin II blockers work directly on angiotensin II.

The research results - more information:

The study is a register-based study of the 1,102,196 Danes who were tested for the coronavirus in the period from 27 February to 26 July 2020. Of these, 13,501 tested positive during the period. In the study, data from the Danish Microbiology Database (MiBa) has been linked with the Danish Register of Medicinal Products, where information was retrieved on the use of medications to lower blood pressure. By linking with the Danish National Patient Register, the Danish Register of Causes of Death and the Civil Registration System, it was possible to study hospitalisation, intensive care hospitalisation and mortality.

The study was conducted as part of the Danish COVID-19 cohort (DACCOVID) in collaboration with, among others, Professor Anton Pottegård from the University of Southern Denmark, Head of Section Marianne Voldstedlund from Statens Serum Institut (SSI), and Director of Division Nikolai Brun from the Danish Medicines Agency.

Aarhus University

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.